Diabetes

Sleep duration, efficiency linked to inpatient hyperglycemia

(HealthDay)—For hospitalized patients, additional sleep and increased sleep efficiency correlate with lower odds of hyperglycemia and impaired fasting glucose, according to research published online Nov. 30 in Diabetes ...

Diabetes

Metformin, sitagliptin prolong normoglycemia remission in DKA

(HealthDay)—For patients with new-onset diabetic ketoacidosis (DKA) and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged ...

Diabetes

Glucose levels linked to cardiac surgery outcomes

(HealthDay)—For patients undergoing cardiac surgery, hyperglycemia is associated with worse outcomes for patients without diabetes, but with better outcomes for patients with insulin-treated diabetes, according to a study ...

Diabetes

Maternal hyperglycemia not linked to obesity in offspring

(HealthDay)—Maternal hyperglycemia seems not to be a risk factor for obesity in offspring aged 5 to 7 years after adjustment for maternal body mass index (BMI), according to a study published online June 19 in Diabetes ...

Diabetes

Glucagon, GLP-1 co-infusion can reduce appetite

(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published ...

Diabetes

In STEMI, hyperglycemia tied to larger myocardial area-at-risk

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), hyperglycemia is associated with larger area-at-risk and infarct size, and the effect of exenatide treatment is independent of glucose levels, ...

Cardiology

Hyperglycemia may increase myocardial infarction mortality

(HealthDay)—Hyperglycemia is common among patients presenting with myocardial infarction and is associated with a higher risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Diabetes

Diabetes testing strips recalled for potential false readings

(HealthDay)—Certain diabetes blood sugar testing strips are being recalled by their maker, Nova Diabetes Care, because they may give users false, abnormally high readings, according to the U.S. Food and Drug Administration.

page 2 from 4